8th International Conference on Management and Rehabilitation of Chronic Respiratory Failure: the Long Summaries

This paper summarizes Part 1 of the proceedings of the 8th International Conference on Management and Rehabilitation of Chronic Respiratory Failure, held in Pescara, Italy, on 7 and 8 May, 2015. It summarizes the contributions from numerous experts in the field of chronic respiratory disease and chronic respiratory failure. The outline follows the temporal sequence of presentations. This paper (Part 1) includes sections regarding: Advances in Asthma and COPD Therapy (Novel Therapeutic Targets for Asthma: Proteinases, Blood Biomarker Changes in COPD Patients); The problem of Hospital Re-Admission following Discharge after the COPD Exacerbation (Characteristics of the Hospitalized COPD Patient, Reducing Hospital Readmissions Following COPD Exacerbation). This paper summarizes Part 2 of the proceedings of the 8th International Conference on Management and Rehabilitation of Chronic Respiratory Failure, held in Pescara, Italy, on 7 and 8 May, 2015. It summarizes the contributions from numerous experts in the field of chronic respiratory disease and chronic respiratory failure. The outline follows the temporal sequence of presentations. This paper (Part 2) includes sections regarding: Promoting Physical Activity across the Spectrum of COPD (Physical activity: definitions, measurements, and significance; Increasing Physical Activity through Pharmacotherapy in COPD); Pulmonary Rehabilitation in Critical Illness (Complex COPD with comorbidities and its impact during acute exacerbation; Collaborative Self-Management in COPD: A Double-Edged Sword?; and Pulmonary Rehabilitation in Critical Illness. This paper summarizes Part 3 of the proceedings of the 8th International Conference on Management and Rehabilitation of Chronic Respiratory Failure, held in Pescara, Italy, on 7 and 8 May, 2015. It summarizes the contributions from numerous experts in the field of chronic respiratory disease and chronic respiratory failure. The outline follows the temporal sequence of presentations. This paper (Part 3) presents a section regarding Moving Across the Spectrum of Care for Long-Term Ventilation (Moving Across the Spectrum of Care for Long-Term Ventilation, New Indications for Non-Invasive Ventilation, Elective Ventilation in Respiratory Failure - Can you Prevent ICU Care in Patients with COPD?, Weaning in Long-Term Acute Care Hospitals in the United States, The Difficult-to-Wean Patient: Comprehensive management, Telemonitoring in Ventilator-Dependent Patients, Ethics and Palliative Care in Critically-Ill Respiratory Patients, and Ethics and Palliative Care in Ventilator-Dependent Patients).

Download Full-text

Clinical Diagnoses, Ventilator Settings, and Blood Gas Characteristics of Pediatric Chronic Respiratory Failure: Children Initiated on Long-Term Ventilation Via Tracheostomy Following Acute Ventilation in a PICU

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3585 ◽

2019 ◽

Author(s):

R. Kretzmer ◽

S. Rubin ◽

T.G. Keens ◽

C.J. Newth

Keyword(s):

Respiratory Failure ◽

Chronic Respiratory Failure ◽

Blood Gas ◽

Clinical Diagnoses ◽

Long Term Ventilation ◽

Ventilator Settings

Download Full-text

Short-term and long-term effects of a self-managed physical activity program using a pedometer for chronic respiratory disease: a randomized controlled trial

Journal of Physical Therapy Science ◽

10.1589/jpts.29.807 ◽

2017 ◽

Vol 29 (5) ◽

pp. 807-812 ◽

Cited By ~ 2

Author(s):

Daigo Kato ◽

Kunio Dobashi ◽

Makoto Fueki ◽

Shinichi Tomioka ◽

Hidenori Yamada ◽

...

Keyword(s):

Physical Activity ◽

Randomized Controlled Trial ◽

Respiratory Disease ◽

Controlled Trial ◽

Chronic Respiratory Disease ◽

Long Term Effects ◽

Short Term ◽

Randomized Controlled ◽

Activity Program

Download Full-text

High frequency of Helicobacter pylori resistant to clarithromycin during long-term multiple antibiotic therapy for chronic respiratory disease caused by non-tuberculosis mycobacterium

Gastroenterology ◽

10.1016/s0016-5085(01)82948-6 ◽

2001 ◽

Vol 120 (5) ◽

pp. A592-A593

Author(s):

F KANEKO ◽

H SUZUKI ◽

N HASEGAWA ◽

S OTANI ◽

H NAKAMIZO ◽

...

Keyword(s):

Helicobacter Pylori ◽

Antibiotic Therapy ◽

Respiratory Disease ◽

High Frequency ◽

Chronic Respiratory Disease

Download Full-text

Chronic respiratory disease and survival outcomes after extracorporeal membrane oxygenation

Respiratory Research ◽

10.1186/s12931-021-01796-8 ◽

2021 ◽

Vol 22 (1) ◽

Author(s):

Tak Kyu Oh ◽

Hyoung-Won Cho ◽

Hun-Taek Lee ◽

In-Ae Song

Keyword(s):

Respiratory Failure ◽

Extracorporeal Membrane Oxygenation ◽

Lung Disease ◽

Respiratory Disease ◽

Chronic Respiratory Disease ◽

Newly Diagnosed ◽

Membrane Oxygenation ◽

Obstructive Sleep ◽

All Cause Mortality ◽

Ecmo Therapy

Abstract Background Quality of life following extracorporeal membrane oxygenation (ECMO) therapy is an important health issue. We aimed to describe the characteristics of patients who developed chronic respiratory disease (CRD) following ECMO therapy, and investigate the association between newly diagnosed post-ECMO CRDs and 5-year all-cause mortality among ECMO survivors. Methods We analyzed data from the National Health Insurance Service in South Korea. All adult patients who underwent ECMO therapy in the intensive care unit between 2006 and 2014 were included. ECMO survivors were defined as those who survived for 365 days after ECMO therapy. Chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, lung cancer, lung disease due to external agents, obstructive sleep apnea, and lung tuberculosis were considered as CRDs. Results A total of 3055 ECMO survivors were included, and 345 (11.3%) were newly diagnosed with CRDs 365 days after ECMO therapy. The prevalence of asthma was the highest at 6.1% (185). In the multivariate logistic regression, ECMO survivors who underwent ECMO therapy for acute respiratory distress syndrome (ARDS) or respiratory failure had a 2.00-fold increase in post-ECMO CRD (95% confidence interval [CI]: 1.39 to 2.89; P < 0.001). In the multivariate Cox regression, newly diagnosed post-ECMO CRD was associated with a 1.47-fold (95% CI: 1.17 to 1.86; P = 0.001) higher 5-year all-cause mortality. Conclusions At 12 months after ECMO therapy, 11.3% of ECMO survivors were newly diagnosed with CRDs. Patients who underwent ECMO therapy for ARDS or respiratory failure were associated with a higher incidence of newly diagnosed post-ECMO CRD compared to those who underwent ECMO for other causes. Additionally, post-ECMO CRDs were associated with a higher 5-year all-cause mortality. Our results suggest that ECMO survivors with newly diagnosed post-ECMO CRD might be a high-risk group requiring dedicated interventions.

Download Full-text

MANAGEMENT OF ACUTE RESPIRATORY FAILURE IN PATIENTS WITH CHRONIC RESPIRATORY DISEASE

Survey of Anesthesiology ◽

10.1097/00132586-196402000-00011 ◽

1964 ◽

Vol 7 (2) ◽

pp. 18???19

Author(s):

J. H. Auchincloss ◽

R. Gilbert ◽

L. D. Epifano

Keyword(s):

Respiratory Failure ◽

Acute Respiratory Failure ◽

Respiratory Disease ◽

Chronic Respiratory Disease

Download Full-text

Oxygen in the home

Drug and Therapeutics Bulletin ◽

10.1136/dtb.20.17.65 ◽

1982 ◽

Vol 20 (17) ◽

pp. 65-67 ◽

Cited By ~ 1

Keyword(s):

Respiratory Disease ◽

Oxygen Therapy ◽

Chronic Respiratory Disease ◽

Term Therapy ◽

High Concentrations ◽

Long Term Therapy ◽

Benefits And Costs ◽

Portable Oxygen

The provision of high concentrations of oxygen is often part of the treatment of cardiac or respiratory disease. The use of domiciliary oxygen is generally limited to those patients with advanced chronic respiratory disease. It can be given in a number of ways - as continuous long-term therapy, as portable oxygen therapy, or intermittently for short periods. This article discusses the benefits and costs.

Download Full-text